3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
5
Lymphoma, Non-Hodgkin
4
Primary Myelofibrosis
3
Myeloproliferative Disorders
3
Recurrence
2
Lymphoma, Follicular
2
Hereditary Sensory and Autonomic Neuropathies
2
Neoplasm Metastasis
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
B-Cell Malignancies
1
Interventions
fludarabine phosphate
23
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
18
Mycophenolic Acid
16
Cyclophosphamide
15
Busulfan
15
Tacrolimus
14
Antilymphocyte Serum
14
Cyclosporine
11
Melphalan
10
Rituximab
9
Methotrexate
9
Etoposide
8
romidepsin
6
Flow Cytometry
6
Filgrastim
6
Vorinostat
5
Dexamethasone
5
thymoglobulin
4
fludarabine
4
Sirolimus
4
Granulocyte Colony-Stimulating Factor
4
Carboplatin
4
Calcium Dobesilate
4
Bexarotene
4
Alemtuzumab
4
Thiotepa
3
Therapeutics
3
Radiotherapy
3
Panobinostat
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Cutaneous
×
parsaclisib
×
Clear all
No trials found.